| Tag | Content |
|---|
EnhancerAtlas ID | HS177-09314 |
Organism | Homo sapiens |
Tissue/cell | SK-N-SH_RA |
Coordinate | chr17:46583130-46583650 |
Target genes | |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| FOSL2 | MA0478.1 | chr17:46583373-46583384 | GGATGACTCAT | + | 6.62 | | Foxa2 | MA0047.2 | chr17:46583182-46583194 | ACTATGTAAACA | - | 6.22 | | JUN(var.2) | MA0489.1 | chr17:46583370-46583384 | AATGGATGACTCAT | + | 6.13 | | JUNB | MA0490.1 | chr17:46583373-46583384 | GGATGACTCAT | + | 6.62 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_51776 | chr17:46583267-46584540 | Skeletal_Muscle_Myoblast | | SE_63564 | chr17:46583156-46584583 | HSMM |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr17 | 46583140 | 46583597 | | chr17 | 46583139 | 46583523 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH17I048505 | chr17 | 46582513 | 46584297 |
|
Enhancer Sequence | CAAAAAGTGT ACAGGCAGTG AGATGTCTGT GAAAGAGGCT CAAAAAGGAA GCACTATGTA 60
AACACCTGCC ACTGTGTACA GCACCAGGTG TGGCTCAACA AACATTTATT GAGGTTATTG 120
TTAAGTATTA GGTCATGCCA AAAAAAAAAG AGAAAACCCA ACTCTTCAAT TTTAGGTTGC 180
ACCATTGAGC TTCTCTTGTC ACATTGCAAA TGTGGTCACT AAGGCAACTG GGCCAGACAG 240
AATGGATGAC TCATCCTGCT CCAACCTAGT ATGCACATCC TGTTGGTCCA GGAGAGTCAC 300
TTCTCATACC ACATGTCCTT GTTCAATGTC AAGGCCTGGA AAATGTCAAA TCATGTCAAA 360
AGTCTCCAGT CCTATATCTC CGTGAAGGTT CAGAGTGAGA ACTGCAGAGC CAGTGGGCAA 420
GACCTGAAAA TTATATTTTG AAAAAGCAGC TGTTGTGAAC ACAAGCCAAA TCACCCTTTC 480
AAAAAGAATT TGGAGGTAAG TCTCAGATAC AGAATTTAAA 520
|
